Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDB1- and CUL4-associated factor 8-like protein 2 (DCAF8L2) is a WD40-repeat-containing protein thought to act as a substrate receptor within the CUL4-DDB1 E3 ubiquitin ligase complex[2][3][5]. As with other DCAF-type proteins, it likely mediates the recruitment of specific substrate proteins for ubiquitin-dependent proteolysis, influencing cellular processes such as chromatin modification, DNA repair, transcription regulation, cell cycle progression, and protein turnover[2][5]. DCAF8L2 is predicted to localize to the nucleus and cytoplasm and is a member of a family of WD40 proteins known for their role in assembling multi-protein complexes, particularly those involved in ubiquitin-mediated cellular regulation[3][5]. While related DCAF proteins and the broader CRL4 complex have mechanistic links to cancer, neurodevelopmental disease, and chromatin regulation, there is currently limited direct evidence that DCAF8L2 itself is a therapeutic target or that any approved drugs interact with it[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 8-like protein 2 (DCAF8L2).